10-K Filing
Filing Information
| Form Type | 10-K |
| Accession Number | 0001564590-18-003549 |
| Period End Date | 20171231 |
| Filing Date | 20180227 |
| Fiscal Year | 2017 |
| Fiscal Period | FY |
| XBRL Instance | zbh-20171231.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
73 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Common stock, par value |
CommonStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Common stock, par value |
CommonStockParOrStatedValuePerShare
|
$0.01 | USD | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
1.00B | shares | Point-in-time |
| Common stock, shares authorized |
CommonStockSharesAuthorized
|
1.00B | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$634.10M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$1.46B | USD | Point-in-time |
| Common stock, shares issued |
CommonStockSharesIssued
|
306.50M | shares | Point-in-time |
| Common stock, shares issued |
CommonStockSharesIssued
|
304.70M | shares | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$524.40M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$1.08B | USD | Point-in-time |
| Treasury stock, shares |
TreasuryStockShares
|
103.90M | shares | Point-in-time |
| Treasury stock, shares |
TreasuryStockShares
|
104.10M | shares | Point-in-time |
| Accounts receivable, less allowance for doubtful accounts |
AccountsReceivableNetCurrent
|
$1.60B | USD | Point-in-time |
| Accounts receivable, less allowance for doubtful accounts |
AccountsReceivableNetCurrent
|
$1.49B | USD | Point-in-time |
| Inventories |
InventoryNet
|
$1.96B | USD | Point-in-time |
| Inventories |
InventoryNet
|
$2.08B | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$465.70M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$414.50M | USD | Point-in-time |
| Total Current Assets |
AssetsCurrent
|
$4.66B | USD | Point-in-time |
| Total Current Assets |
AssetsCurrent
|
$4.52B | USD | Point-in-time |
| Property, plant and equipment, net |
PropertyPlantAndEquipmentNet
|
$2.04B | USD | Point-in-time |
| Property, plant and equipment, net |
PropertyPlantAndEquipmentNet
|
$2.04B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$9.93B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$10.64B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$10.67B | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$8.79B | USD | Point-in-time |
| Intangible assets, net |
IntangibleAssetsNetExcludingGoodwill
|
$8.35B | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$388.80M | USD | Point-in-time |
| Other assets |
OtherAssetsNoncurrent
|
$553.60M | USD | Point-in-time |
| Total Assets |
Assets
|
$26.68B | USD | Point-in-time |
| Total Assets |
Assets
|
$25.96B | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$364.50M | USD | Point-in-time |
| Accounts payable |
AccountsPayableCurrent
|
$330.20M | USD | Point-in-time |
| Income taxes payable |
AccruedIncomeTaxesCurrent
|
$165.20M | USD | Point-in-time |
| Income taxes payable |
AccruedIncomeTaxesCurrent
|
$183.50M | USD | Point-in-time |
| Other current liabilities |
OtherLiabilitiesCurrent
|
$1.30B | USD | Point-in-time |
| Other current liabilities |
OtherLiabilitiesCurrent
|
$1.26B | USD | Point-in-time |
| Current portion of long-term debt |
LongTermDebtCurrent
|
$575.60M | USD | Point-in-time |
| Current portion of long-term debt |
LongTermDebtCurrent
|
$1.23B | USD | Point-in-time |
| Total Current Liabilities |
LiabilitiesCurrent
|
$3.02B | USD | Point-in-time |
| Total Current Liabilities |
LiabilitiesCurrent
|
$2.38B | USD | Point-in-time |
| Deferred income taxes, net |
DeferredTaxLiabilitiesNoncurrent
|
$1.10B | USD | Point-in-time |
| Deferred income taxes, net |
DeferredTaxLiabilitiesNoncurrent
|
$3.03B | USD | Point-in-time |
| Long-term income tax payable |
AccruedIncomeTaxesNoncurrent
|
$473.70M | USD | Point-in-time |
| Long-term income tax payable |
AccruedIncomeTaxesNoncurrent
|
$744.00M | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$462.60M | USD | Point-in-time |
| Other long-term liabilities |
OtherLiabilitiesNoncurrent
|
$445.80M | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$8.92B | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$10.67B | USD | Point-in-time |
| Total Liabilities |
Liabilities
|
$17.01B | USD | Point-in-time |
| Total Liabilities |
Liabilities
|
$14.23B | USD | Point-in-time |
| Commitments and Contingencies (Note 19) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and Contingencies (Note 19) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Common stock, $0.01 par value, one billion shares authorized, 306.5 million (304.7 million in 2016) issued |
CommonStockValue
|
$3.10M | USD | Point-in-time |
| Common stock, $0.01 par value, one billion shares authorized, 306.5 million (304.7 million in 2016) issued |
CommonStockValue
|
$3.10M | USD | Point-in-time |
| Paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$8.51B | USD | Point-in-time |
| Paid-in capital |
AdditionalPaidInCapitalCommonStock
|
$8.37B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$8.47B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$10.02B | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-83.20M | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-434.00M | USD | Point-in-time |
| Treasury stock, 103.9 million shares (104.1 million shares in 2016) |
TreasuryStockValue
|
$6.72B | USD | Point-in-time |
| Treasury stock, 103.9 million shares (104.1 million shares in 2016) |
TreasuryStockValue
|
$6.74B | USD | Point-in-time |
| Total Zimmer Biomet Holdings, Inc. stockholders' equity |
StockholdersEquity
|
$11.74B | USD | Point-in-time |
| Total Zimmer Biomet Holdings, Inc. stockholders' equity |
StockholdersEquity
|
$9.67B | USD | Point-in-time |
| Noncontrolling interest |
MinorityInterest
|
$-300.00K | USD | Point-in-time |
| Noncontrolling interest |
MinorityInterest
|
$1.00M | USD | Point-in-time |
| Total Stockholders' Equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.55B | USD | Point-in-time |
| Total Stockholders' Equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$9.67B | USD | Point-in-time |
| Total Stockholders' Equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$11.74B | USD | Point-in-time |
| Total Stockholders' Equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$9.89B | USD | Point-in-time |
| Total Liabilities and Stockholders' Equity |
LiabilitiesAndStockholdersEquity
|
$25.96B | USD | Point-in-time |
| Total Liabilities and Stockholders' Equity |
LiabilitiesAndStockholdersEquity
|
$26.68B | USD | Point-in-time |
Income Statement
96 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net Sales |
SalesRevenueGoodsNet
|
$2.01B | USD | 1 Quarter |
| Net Sales |
SalesRevenueGoodsNet
|
$6.00B | USD | Annual |
| Net Sales |
SalesRevenueGoodsNet
|
$2.07B | USD | 1 Quarter |
| Net Sales |
SalesRevenueGoodsNet
|
$1.83B | USD | 1 Quarter |
| Net Sales |
SalesRevenueGoodsNet
|
$7.82B | USD | Annual |
| Net Sales |
SalesRevenueGoodsNet
|
$1.90B | USD | 1 Quarter |
| Net Sales |
SalesRevenueGoodsNet
|
$1.82B | USD | 1 Quarter |
| Net Sales |
SalesRevenueGoodsNet
|
$7.68B | USD | Annual |
| Net Sales |
SalesRevenueGoodsNet
|
$1.98B | USD | 1 Quarter |
| Net Sales |
SalesRevenueGoodsNet
|
$1.93B | USD | 1 Quarter |
| Net Sales |
SalesRevenueGoodsNet
|
$1.95B | USD | 1 Quarter |
| Cost of products sold, excluding intangible asset amortization |
CostOfGoodsSold
|
$2.38B | USD | Annual |
| Cost of products sold, excluding intangible asset amortization |
CostOfGoodsSold
|
$2.13B | USD | Annual |
| Cost of products sold, excluding intangible asset amortization |
CostOfGoodsSold
|
$1.80B | USD | Annual |
| Intangible asset amortization |
AmortizationOfIntangibleAssets
|
$337.40M | USD | Annual |
| Intangible asset amortization |
AmortizationOfIntangibleAssets
|
$603.90M | USD | Annual |
| Intangible asset amortization |
AmortizationOfIntangibleAssets
|
$565.90M | USD | Annual |
| Research and development |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$365.60M | USD | Annual |
| Research and development |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$268.80M | USD | Annual |
| Research and development |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$367.40M | USD | Annual |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$2.28B | USD | Annual |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$2.97B | USD | Annual |
| Selling, general and administrative |
SellingGeneralAndAdministrativeExpense
|
$2.93B | USD | Annual |
| Goodwill impairment |
GoodwillImpairmentLoss
|
$304.70M | USD | Annual |
| Special items (Note 2) |
SpecialItems
|
$839.50M | USD | Annual |
| Special items (Note 2) |
SpecialItems
|
$611.80M | USD | Annual |
| Special items (Note 2) |
SpecialItems
|
$633.10M | USD | Annual |
| Operating expenses |
CostsAndExpenses
|
$7.02B | USD | Annual |
| Operating expenses |
CostsAndExpenses
|
$6.86B | USD | Annual |
| Operating expenses |
CostsAndExpenses
|
$5.53B | USD | Annual |
| Operating Profit |
OperatingIncomeLoss
|
$825.90M | USD | Annual |
| Operating Profit |
OperatingIncomeLoss
|
$467.30M | USD | Annual |
| Operating Profit |
OperatingIncomeLoss
|
$808.20M | USD | Annual |
| Other expense, net |
OtherNonoperatingIncomeExpense
|
$-71.30M | USD | Annual |
| Other expense, net |
OtherNonoperatingIncomeExpense
|
$-36.90M | USD | Annual |
| Other expense, net |
OtherNonoperatingIncomeExpense
|
$-18.30M | USD | Annual |
| Interest income |
InvestmentIncomeInterest
|
$9.40M | USD | Annual |
| Interest income |
InvestmentIncomeInterest
|
$2.90M | USD | Annual |
| Interest income |
InvestmentIncomeInterest
|
$2.20M | USD | Annual |
| Interest expense |
InterestExpenseDebt
|
$327.50M | USD | Annual |
| Interest expense |
InterestExpenseDebt
|
$286.60M | USD | Annual |
| Interest expense |
InterestExpenseDebt
|
$357.90M | USD | Annual |
| Earnings before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$464.60M | USD | Annual |
| Earnings before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$399.60M | USD | Annual |
| Earnings before income taxes |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$153.20M | USD | Annual |
| (Benefit) provision for income taxes |
IncomeTaxExpenseBenefit
|
$-1.35B | USD | Annual |
| (Benefit) provision for income taxes |
IncomeTaxExpenseBenefit
|
$7.00M | USD | Annual |
| (Benefit) provision for income taxes |
IncomeTaxExpenseBenefit
|
$95.00M | USD | Annual |
| Net earnings |
ProfitLoss
|
$1.81B | USD | Annual |
| Net earnings |
ProfitLoss
|
$304.60M | USD | Annual |
| Net earnings |
ProfitLoss
|
$146.20M | USD | Annual |
| Less: Net loss attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-800.00K | USD | Annual |
| Less: Net loss attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-400.00K | USD | Annual |
| Less: Net loss attributable to noncontrolling interest |
NetIncomeLossAttributableToNoncontrollingInterest
|
$-1.30M | USD | Annual |
| Net Earnings of Zimmer Biomet Holdings, Inc. |
NetIncomeLoss
|
$98.80M | USD | 1 Quarter |
| Net Earnings of Zimmer Biomet Holdings, Inc. |
NetIncomeLoss
|
$147.00M | USD | Annual |
| Net Earnings of Zimmer Biomet Holdings, Inc. |
NetIncomeLoss
|
$-31.30M | USD | 1 Quarter |
| Net Earnings of Zimmer Biomet Holdings, Inc. |
NetIncomeLoss
|
$305.90M | USD | Annual |
| Net Earnings of Zimmer Biomet Holdings, Inc. |
NetIncomeLoss
|
$158.80M | USD | 1 Quarter |
| Net Earnings of Zimmer Biomet Holdings, Inc. |
NetIncomeLoss
|
$69.60M | USD | 1 Quarter |
| Net Earnings of Zimmer Biomet Holdings, Inc. |
NetIncomeLoss
|
$1.81B | USD | Annual |
| Net Earnings of Zimmer Biomet Holdings, Inc. |
NetIncomeLoss
|
$1.23B | USD | 1 Quarter |
| Net Earnings of Zimmer Biomet Holdings, Inc. |
NetIncomeLoss
|
$108.80M | USD | 1 Quarter |
| Net Earnings of Zimmer Biomet Holdings, Inc. |
NetIncomeLoss
|
$299.40M | USD | 1 Quarter |
| Net Earnings of Zimmer Biomet Holdings, Inc. |
NetIncomeLoss
|
$184.20M | USD | 1 Quarter |
| Earnings Per Common Share - Basic |
EarningsPerShareBasic
|
$0.79 | USD | 1 Quarter |
| Earnings Per Common Share - Basic |
EarningsPerShareBasic
|
$0.35 | USD | 1 Quarter |
| Earnings Per Common Share - Basic |
EarningsPerShareBasic
|
$0.49 | USD | 1 Quarter |
| Earnings Per Common Share - Basic |
EarningsPerShareBasic
|
$0.91 | USD | 1 Quarter |
| Earnings Per Common Share - Basic |
EarningsPerShareBasic
|
$1.53 | USD | Annual |
| Earnings Per Common Share - Basic |
EarningsPerShareBasic
|
$0.54 | USD | 1 Quarter |
| Earnings Per Common Share - Basic |
EarningsPerShareBasic
|
$8.98 | USD | Annual |
| Earnings Per Common Share - Basic |
EarningsPerShareBasic
|
$0.78 | USD | Annual |
| Earnings Per Common Share - Basic |
EarningsPerShareBasic
|
$1.49 | USD | 1 Quarter |
| Earnings Per Common Share - Basic |
EarningsPerShareBasic
|
$6.08 | USD | 1 Quarter |
| Earnings Per Common Share - Basic |
EarningsPerShareBasic
|
$-0.16 | USD | 1 Quarter |
| Earnings Per Common Share - Diluted |
EarningsPerShareDiluted
|
$0.90 | USD | 1 Quarter |
| Earnings Per Common Share - Diluted |
EarningsPerShareDiluted
|
$0.34 | USD | 1 Quarter |
| Earnings Per Common Share - Diluted |
EarningsPerShareDiluted
|
$0.48 | USD | 1 Quarter |
| Earnings Per Common Share - Diluted |
EarningsPerShareDiluted
|
$1.47 | USD | 1 Quarter |
| Earnings Per Common Share - Diluted |
EarningsPerShareDiluted
|
$1.51 | USD | Annual |
| Earnings Per Common Share - Diluted |
EarningsPerShareDiluted
|
$8.90 | USD | Annual |
| Earnings Per Common Share - Diluted |
EarningsPerShareDiluted
|
$6.03 | USD | 1 Quarter |
| Earnings Per Common Share - Diluted |
EarningsPerShareDiluted
|
$0.77 | USD | Annual |
| Earnings Per Common Share - Diluted |
EarningsPerShareDiluted
|
$-0.16 | USD | 1 Quarter |
| Earnings Per Common Share - Diluted |
EarningsPerShareDiluted
|
$0.78 | USD | 1 Quarter |
| Earnings Per Common Share - Diluted |
EarningsPerShareDiluted
|
$0.54 | USD | 1 Quarter |
| Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
187.40M | shares | Annual |
| Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
200.00M | shares | Annual |
| Basic |
WeightedAverageNumberOfSharesOutstandingBasic
|
201.90M | shares | Annual |
| Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
189.80M | shares | Annual |
| Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
203.70M | shares | Annual |
| Diluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
202.40M | shares | Annual |
| Cash Dividends Declared Per Common Share |
CommonStockDividendsPerShareDeclared
|
$0.88 | USD | Annual |
| Cash Dividends Declared Per Common Share |
CommonStockDividendsPerShareDeclared
|
$0.96 | USD | Annual |
| Cash Dividends Declared Per Common Share |
CommonStockDividendsPerShareDeclared
|
$0.96 | USD | Annual |
Cash Flow Statement
109 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net earnings |
ProfitLoss
|
$1.81B | USD | Annual |
| Net earnings |
ProfitLoss
|
$304.60M | USD | Annual |
| Net earnings |
ProfitLoss
|
$146.20M | USD | Annual |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$712.40M | USD | Annual |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$1.04B | USD | Annual |
| Depreciation and amortization |
DepreciationDepletionAndAmortization
|
$1.06B | USD | Annual |
| Biomet merger consideration compensation expense |
BusinessCombinationConsiderationCompensationExpense
|
$90.40M | USD | Annual |
| Share-based compensation |
ShareBasedCompensation
|
$53.70M | USD | Annual |
| Share-based compensation |
ShareBasedCompensation
|
$46.40M | USD | Annual |
| Share-based compensation |
ShareBasedCompensation
|
$57.30M | USD | Annual |
| Goodwill and intangible asset impairment |
GoodwillAndIntangibleAssetImpairment
|
$30.00M | USD | Annual |
| Goodwill and intangible asset impairment |
GoodwillAndIntangibleAssetImpairment
|
$331.50M | USD | Annual |
| Excess income tax benefit from stock option exercises |
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
|
$11.80M | USD | Annual |
| Inventory step-up |
InventoryStepUp
|
$323.30M | USD | Annual |
| Inventory step-up |
InventoryStepUp
|
$317.80M | USD | Annual |
| Inventory step-up |
InventoryStepUp
|
$32.80M | USD | Annual |
| Gain on divestiture of assets |
GainLossOnDispositionOfAssets1
|
$19.00M | USD | Annual |
| Debt extinguishment |
GainsLossesOnExtinguishmentOfDebt
|
$-53.30M | USD | Annual |
| Debt extinguishment |
GainsLossesOnExtinguishmentOfDebt
|
$-22.00M | USD | Annual |
| Deferred income tax provision |
DeferredIncomeTaxExpenseBenefit
|
$-153.20M | USD | Annual |
| Deferred income tax provision |
DeferredIncomeTaxExpenseBenefit
|
$-164.00M | USD | Annual |
| Deferred income tax provision |
DeferredIncomeTaxExpenseBenefit
|
$-1.78B | USD | Annual |
| Income taxes |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$-10.90M | USD | Annual |
| Income taxes |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$150.20M | USD | Annual |
| Income taxes |
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
$244.70M | USD | Annual |
| Receivables |
IncreaseDecreaseInReceivables
|
$56.10M | USD | Annual |
| Receivables |
IncreaseDecreaseInReceivables
|
$-176.50M | USD | Annual |
| Receivables |
IncreaseDecreaseInReceivables
|
$137.80M | USD | Annual |
| Inventories |
IncreaseDecreaseInInventories
|
$122.80M | USD | Annual |
| Inventories |
IncreaseDecreaseInInventories
|
$205.40M | USD | Annual |
| Inventories |
IncreaseDecreaseInInventories
|
$-76.40M | USD | Annual |
| Accounts payable and accrued liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-148.20M | USD | Annual |
| Accounts payable and accrued liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-252.00M | USD | Annual |
| Accounts payable and accrued liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$28.70M | USD | Annual |
| Other assets and liabilities |
IncreaseDecreaseInOtherOperatingCapitalNet
|
$-8.50M | USD | Annual |
| Other assets and liabilities |
IncreaseDecreaseInOtherOperatingCapitalNet
|
$21.80M | USD | Annual |
| Other assets and liabilities |
IncreaseDecreaseInOtherOperatingCapitalNet
|
$-21.20M | USD | Annual |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
$849.80M | USD | Annual |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
$1.63B | USD | Annual |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
$1.58B | USD | Annual |
| Additions to instruments |
AdditionsToInstruments
|
$345.50M | USD | Annual |
| Additions to instruments |
AdditionsToInstruments
|
$266.40M | USD | Annual |
| Additions to instruments |
AdditionsToInstruments
|
$337.00M | USD | Annual |
| Additions to other property, plant and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$167.70M | USD | Annual |
| Additions to other property, plant and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$184.70M | USD | Annual |
| Additions to other property, plant and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$156.00M | USD | Annual |
| Purchases of investments |
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
$1.50M | USD | Annual |
| Purchases of investments |
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
$214.80M | USD | Annual |
| Sales of investments |
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
$802.90M | USD | Annual |
| Sales of investments |
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
$286.20M | USD | Annual |
| Proceeds from divestiture of assets |
ProceedsFromSaleOfProductiveAssets
|
$69.90M | USD | Annual |
| Business combination investments, net of acquired cash |
PaymentsToAcquireBusinessTwoNetOfCashAcquired
|
$421.90M | USD | Annual |
| Business combination investments, net of acquired cash |
PaymentsToAcquireBusinessTwoNetOfCashAcquired
|
$4.00M | USD | Annual |
| Investments in other assets |
PaymentsForProceedsFromOtherInvestingActivities
|
$13.80M | USD | Annual |
| Investments in other assets |
PaymentsForProceedsFromOtherInvestingActivities
|
$21.70M | USD | Annual |
| Investments in other assets |
PaymentsForProceedsFromOtherInvestingActivities
|
$3.00M | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
$-510.80M | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
$-7.56B | USD | Annual |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
$-1.69B | USD | Annual |
| Proceeds from senior notes |
ProceedsFromIssuanceOfSeniorLongTermDebt
|
$1.07B | USD | Annual |
| Proceeds from senior notes |
ProceedsFromIssuanceOfSeniorLongTermDebt
|
$7.63B | USD | Annual |
| Proceeds from multicurrency revolving facility |
ProceedsFromLinesOfCredit
|
$400.00M | USD | Annual |
| Payments on multicurrency revolving facility |
RepaymentsOfLinesOfCredit
|
$400.00M | USD | Annual |
| Redemption of senior notes |
MaturitiesOfSeniorDebt
|
$1.25B | USD | Annual |
| Redemption of senior notes |
MaturitiesOfSeniorDebt
|
$500.00M | USD | Annual |
| Redemption of senior notes |
MaturitiesOfSeniorDebt
|
$2.76B | USD | Annual |
| Proceeds from term loan |
ProceedsFromIssuanceOfUnsecuredDebt
|
$3.00B | USD | Annual |
| Proceeds from term loan |
ProceedsFromIssuanceOfUnsecuredDebt
|
$750.00M | USD | Annual |
| Proceeds from term loan |
ProceedsFromIssuanceOfUnsecuredDebt
|
$192.70M | USD | Annual |
| Payments on term loan |
RepaymentsOfLongTermDebt
|
$500.00M | USD | Annual |
| Payments on term loan |
RepaymentsOfLongTermDebt
|
$940.00M | USD | Annual |
| Payments on term loan |
RepaymentsOfLongTermDebt
|
$800.00M | USD | Annual |
| Net (payments) proceeds on other debt |
ProceedsFromRepaymentsOfOtherDebt
|
$-33.10M | USD | Annual |
| Net (payments) proceeds on other debt |
ProceedsFromRepaymentsOfOtherDebt
|
$100.00K | USD | Annual |
| Net (payments) proceeds on other debt |
ProceedsFromRepaymentsOfOtherDebt
|
$-900.00K | USD | Annual |
| Dividends paid to stockholders |
PaymentsOfDividendsCommonStock
|
$157.10M | USD | Annual |
| Dividends paid to stockholders |
PaymentsOfDividendsCommonStock
|
$188.40M | USD | Annual |
| Dividends paid to stockholders |
PaymentsOfDividendsCommonStock
|
$193.60M | USD | Annual |
| Proceeds from employee stock compensation plans |
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
$136.60M | USD | Annual |
| Proceeds from employee stock compensation plans |
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
$145.50M | USD | Annual |
| Proceeds from employee stock compensation plans |
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
$105.20M | USD | Annual |
| Unremitted collections from factoring programs |
CashFlowsBetweenTransfereeAndTransferorReceiptsOnInterestsThatContinueToBeHeldOther
|
$103.50M | USD | Annual |
| Business combination contingent consideration payments |
PaymentForContingentConsiderationLiabilityFinancingActivities
|
$9.10M | USD | Annual |
| Restricted stock withholdings |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
$6.30M | USD | Annual |
| Restricted stock withholdings |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
$8.30M | USD | Annual |
| Restricted stock withholdings |
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
|
$11.10M | USD | Annual |
| Excess income tax benefit from stock option exercises |
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
|
$11.80M | USD | Annual |
| Debt issuance costs |
PaymentsOfDebtIssuanceCosts
|
$10.00M | USD | Annual |
| Debt issuance costs |
PaymentsOfDebtIssuanceCosts
|
$300.00K | USD | Annual |
| Debt issuance costs |
PaymentsOfDebtIssuanceCosts
|
$58.40M | USD | Annual |
| Repurchase of common stock |
PaymentsForRepurchaseOfCommonStock
|
$150.00M | USD | Annual |
| Repurchase of common stock |
PaymentsForRepurchaseOfCommonStock
|
$415.50M | USD | Annual |
| Net cash (used in) provided by financing activities |
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
$-1.21B | USD | Annual |
| Net cash (used in) provided by financing activities |
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
$-743.20M | USD | Annual |
| Net cash (used in) provided by financing activities |
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
$7.11B | USD | Annual |
| Effect of exchange rates on cash and cash equivalents |
EffectOfExchangeRateOnCashAndCashEquivalents
|
$29.30M | USD | Annual |
| Effect of exchange rates on cash and cash equivalents |
EffectOfExchangeRateOnCashAndCashEquivalents
|
$-22.60M | USD | Annual |
| Effect of exchange rates on cash and cash equivalents |
EffectOfExchangeRateOnCashAndCashEquivalents
|
$-22.70M | USD | Annual |
| (Decrease) increase in cash and cash equivalents |
CashAndCashEquivalentsPeriodIncreaseDecrease
|
$376.00M | USD | Annual |
| (Decrease) increase in cash and cash equivalents |
CashAndCashEquivalentsPeriodIncreaseDecrease
|
$-109.70M | USD | Annual |
| (Decrease) increase in cash and cash equivalents |
CashAndCashEquivalentsPeriodIncreaseDecrease
|
$-825.20M | USD | Annual |
| Cash and cash equivalents, beginning of year |
CashAndCashEquivalentsAtCarryingValue
|
$634.10M | USD | Point-in-time |
| Cash and cash equivalents, beginning of year |
CashAndCashEquivalentsAtCarryingValue
|
$1.46B | USD | Point-in-time |
| Cash and cash equivalents, beginning of year |
CashAndCashEquivalentsAtCarryingValue
|
$524.40M | USD | Point-in-time |
| Cash and cash equivalents, beginning of year |
CashAndCashEquivalentsAtCarryingValue
|
$1.08B | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashAndCashEquivalentsAtCarryingValue
|
$634.10M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashAndCashEquivalentsAtCarryingValue
|
$1.46B | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashAndCashEquivalentsAtCarryingValue
|
$524.40M | USD | Point-in-time |
| Cash and cash equivalents, end of period |
CashAndCashEquivalentsAtCarryingValue
|
$1.08B | USD | Point-in-time |
Stockholders Equity
25 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.55B | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$9.67B | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$11.74B | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$9.89B | USD | Point-in-time |
| Net earnings |
ProfitLoss
|
$1.81B | USD | Annual |
| Net earnings |
ProfitLoss
|
$304.60M | USD | Annual |
| Net earnings |
ProfitLoss
|
$146.20M | USD | Annual |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-366.60M | USD | Annual |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$349.90M | USD | Annual |
| Other comprehensive income (loss) |
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
|
$-104.20M | USD | Annual |
| Cash dividends declared |
DividendsCommonStockCash
|
$164.40M | USD | Annual |
| Cash dividends declared |
DividendsCommonStockCash
|
$194.10M | USD | Annual |
| Cash dividends declared |
DividendsCommonStockCash
|
$191.90M | USD | Annual |
| Retrospective adoption ofnew accounting standard |
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
|
$-77.80M | USD | Annual |
| Stock compensation plans |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$174.20M | USD | Annual |
| Stock compensation plans |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$187.50M | USD | Annual |
| Stock compensation plans |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$149.80M | USD | Annual |
| Share repurchases |
TreasuryStockValueAcquiredCostMethod
|
$150.00M | USD | Annual |
| Share repurchases |
TreasuryStockValueAcquiredCostMethod
|
$415.50M | USD | Annual |
| Share repurchases, shares |
TreasuryStockSharesAcquired
|
4.20M | shares | Annual |
| Biomet merger consideration |
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
|
$3.72B | USD | Annual |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$6.55B | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$9.67B | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$11.74B | USD | Point-in-time |
| Balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$9.89B | USD | Point-in-time |
Comprehensive Income
29 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net Earnings |
ProfitLoss
|
$1.81B | USD | Annual |
| Net Earnings |
ProfitLoss
|
$304.60M | USD | Annual |
| Net Earnings |
ProfitLoss
|
$146.20M | USD | Annual |
| Foreign currency cumulative translation adjustments, net of tax |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
$445.00M | USD | Annual |
| Foreign currency cumulative translation adjustments, net of tax |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
$-305.20M | USD | Annual |
| Foreign currency cumulative translation adjustments, net of tax |
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
|
$-130.00M | USD | Annual |
| Unrealized cash flow hedge (losses)/gains, net of tax |
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
$-95.00M | USD | Annual |
| Unrealized cash flow hedge (losses)/gains, net of tax |
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
$28.30M | USD | Annual |
| Unrealized cash flow hedge (losses)/gains, net of tax |
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
|
$52.70M | USD | Annual |
| Reclassification adjustments on cash flow hedges, net of tax |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
|
$93.00M | USD | Annual |
| Reclassification adjustments on cash flow hedges, net of tax |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
|
$3.80M | USD | Annual |
| Reclassification adjustments on cash flow hedges, net of tax |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
|
$25.80M | USD | Annual |
| Unrealized gains/(losses) on securities, net of tax |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-200.00K | USD | Annual |
| Unrealized gains/(losses) on securities, net of tax |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$500.00K | USD | Annual |
| Adjustments to prior service cost and unrecognized actuarial assumptions, net of tax |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
$21.40M | USD | Annual |
| Adjustments to prior service cost and unrecognized actuarial assumptions, net of tax |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
$-22.00M | USD | Annual |
| Adjustments to prior service cost and unrecognized actuarial assumptions, net of tax |
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
$-4.60M | USD | Annual |
| Total Other Comprehensive Income (Loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$350.80M | USD | Annual |
| Total Other Comprehensive Income (Loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-105.00M | USD | Annual |
| Total Other Comprehensive Income (Loss) |
OtherComprehensiveIncomeLossNetOfTax
|
$-367.10M | USD | Annual |
| Comprehensive Income (Loss) |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$-220.90M | USD | Annual |
| Comprehensive Income (Loss) |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$199.60M | USD | Annual |
| Comprehensive Income (Loss) |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$2.16B | USD | Annual |
| Comprehensive Loss Attributable to Noncontrolling Interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$-500.00K | USD | Annual |
| Comprehensive Loss Attributable to Noncontrolling Interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$-300.00K | USD | Annual |
| Comprehensive Loss Attributable to Noncontrolling Interest |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$-1.30M | USD | Annual |
| Comprehensive Income (Loss) Attributable to Zimmer Biomet Holdings, Inc. |
ComprehensiveIncomeNetOfTax
|
$-220.60M | USD | Annual |
| Comprehensive Income (Loss) Attributable to Zimmer Biomet Holdings, Inc. |
ComprehensiveIncomeNetOfTax
|
$200.10M | USD | Annual |
| Comprehensive Income (Loss) Attributable to Zimmer Biomet Holdings, Inc. |
ComprehensiveIncomeNetOfTax
|
$2.17B | USD | Annual |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.